PW Medtech Group Ltd (HKG: 1358), a prominent medical device manufacturer based in China, is planning to spin off its subsidiary, Sichuan Rekind Medtec., Inc., for an independent listing on the National Equities Exchange and Quotations (NEEQ). Established in 2013, Rekind specializes in the research, development, manufacturing, and marketing of blood purification medical devices. This strategic move aims to broaden financing channels, strengthen financing capabilities, capitalize on market growth opportunities, and bolster sales and market share.- Flcube.com
Recent news:
-
Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation -
Leman Biotech Enters Zhongshan Life Science Park to Accelerate CAR-T Innovation -
BRL Medicine Inc. Secures Nearly $30 Million in B+ Round Financing to Advance Pipeline -
Chinese Biopharma Bio-Bank Corp. Aims for HKEX IPO, Focused on PDGF Therapies -
HutchMed Anticipates Milestone Payment as Takeda Launches Fruzaqla in Japan for CRC
